Aurobindo Pharma: Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors - Buyback Of Shares

The Board of the Aurobindo Pharma Limited at its meeting held today (i.e. April 6 2026) has inter-alia considered and approved subject to such approvals of regulatory and/or statutory authorities as may be required under applicable laws the buyback of up to 54 23 728 (Fifty four lakhs twenty three thousand seven hundred and twenty eight only) fully paid-up equity shares of the Company each having a face value of INR 1/- (Indian Rupee one only).